Compounds > nitrites

nitrites and fenofibrate

nitrites has been researched along with fenofibrate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, MF; Jiang, JL; Li, YJ; Luo, BL; Yang, TL; Yu, J1
Balakumar, P; Kaur, J; Reddy, K1
Bhateja, DK; Dhull, DK; Gill, A; Padi, SS; Reddy, BV; Sharma, S; Sidhu, A1
Al-Ajmi, HN; Al-Amin, MA; Al-Rasheed, NM; Attia, HA; Hasan, IH; Mohamad, RA; Sinjilawi, NA1
Abdel-Hafez, SMN; Abdelzaher, WY; Ali, AHSA; Bahaa, HA; Hegazy, A; Rofaeil, RR1

Other Studies

5 other study(ies) available for nitrites and fenofibrate

ArticleYear
Effect of fenofibrate on LDL-induced endothelial dysfunction in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:2

    Topics: Acetylcholine; Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Arginine; Creatinine; Endothelium, Vascular; Fenofibrate; Hypolipidemic Agents; In Vitro Techniques; Male; Malondialdehyde; Muscle, Smooth, Vascular; Nitrates; Nitrites; Phenylephrine; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Vasodilation

2004
The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
    Cardiovascular toxicology, 2010, Volume: 10, Issue:3

    Topics: Animals; Arsenites; Cholesterol; Endothelium, Vascular; Fenofibrate; Hypolipidemic Agents; In Vitro Techniques; Lipid Metabolism; Lipoproteins, HDL; Microscopy, Electron, Scanning; Nicotine; Nicotinic Antagonists; Nitrates; Nitrites; Rats; Rats, Wistar; Sodium Compounds; Superoxides; Thiobarbituric Acid Reactive Substances; Triglycerides; Vascular Diseases

2010
Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
    European journal of pharmacology, 2012, Jan-05, Volume: 674, Issue:1

    Topics: Animals; Behavior, Animal; Body Weight; Brain; Catalase; Cytokines; Extremities; Fenofibrate; Glutathione; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Neurotoxins; Nitrites; Nitro Compounds; Oxidative Stress; PPAR alpha; Propionates; Protein Carbonylation; Rats; Rats, Wistar; Retention, Psychology; Succinate Dehydrogenase; Superoxide Dismutase

2012
Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy.
    Pharmacology, 2015, Volume: 95, Issue:5-6

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Blood Glucose; Diabetic Nephropathies; Fenofibrate; Hypolipidemic Agents; Kidney; Lipid Metabolism; Male; Nitric Oxide Synthase Type III; Nitrites; Protective Agents; Protein Serine-Threonine Kinases; Rats, Wistar; RNA, Messenger

2015
The protective effect of fenofibrate, triptorelin, and their combination against premature ovarian failure in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:1

    Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Combinations; Drug Therapy, Combination; Female; Fenofibrate; Glutathione; Hormones; Interleukin-10; Malondialdehyde; Nitrites; Ovary; Oxidative Stress; Primary Ovarian Insufficiency; Protective Agents; Rats, Wistar; Superoxide Dismutase; Triptorelin Pamoate; Tumor Necrosis Factor-alpha

2021